| Schedule of Earnings Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share (unaudited) during the three and
six months ended June 30, 2022 and 2021:
Schedule
of Earnings Per Share
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| |
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss from continuing operations |
|
$ |
(499,841 |
) |
|
$ |
(1,490,097 |
) |
|
$ |
(2,765,973 |
) |
|
$ |
(5,157,425 |
) |
| Deemed dividends |
|
|
(194,951,624 |
) |
|
|
(99,253,330 |
) |
|
|
(330,876,369 |
) |
|
|
(149,611,479 |
) |
| Net loss available to common stockholders, continuing operations |
|
|
(195,451,465 |
) |
|
|
(100,743,427 |
) |
|
|
(333,642,342 |
) |
|
|
(154,768,904 |
) |
| Net (loss) income from discontinued operations |
|
|
(3,945 |
) |
|
|
10,561,415 |
|
|
|
(5,379 |
) |
|
|
10,334,749 |
|
| Net loss available to common stockholders |
|
$ |
(195,455,410 |
) |
|
$ |
(90,182,012 |
) |
|
$ |
(333,647,721 |
) |
|
$ |
(144,434,155 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average number of shares of common stock outstanding during the period - basic and diluted |
|
|
1,702,149,425 |
|
|
|
731 |
|
|
|
858,169,865 |
|
|
|
380 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share of common stock available to common stockholders - basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Continuing operations |
|
$ |
(0.11 |
) |
|
$ |
(137,815.91 |
) |
|
$ |
(0.39 |
) |
|
$ |
(407,286.59 |
) |
| Discontinued operations |
|
|
(0.00 |
) |
|
|
14,447.90 |
|
|
|
(0.00 |
) |
|
|
27,196.71 |
|
| Total basic and diluted |
|
$ |
(0.11 |
) |
|
$ |
(123,368.01 |
) |
|
$ |
(0.39 |
) |
|
$ |
(380,089.88 |
) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
loss per share excludes all dilutive potential shares if their effect is anti-dilutive. As of June 30, 2022 and 2021, the following potential
common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
Schedule
of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
| |
|
Six Months Ended June 30, |
|
| |
|
2022 |
|
|
2021 |
|
| Warrants |
|
|
511,333,351,097 |
|
|
|
12,247 |
|
| Convertible preferred stock |
|
|
477,576,633,334 |
|
|
|
8,586 |
|
| Convertible debentures |
|
|
28,777,833,333 |
|
|
|
596 |
|
| Stock options |
|
|
26 |
|
|
|
26 |
|
| |
|
|
1,017,687,817,790 |
|
|
|
21,455 |
|
|